PRKN and Parkinson disease: Isil Ezgi Eryilmaza et al., in 2017, observed that variations in the methylation patterns increased the transcription regulation of PARK2, which resulted in mitochondrial dysfunction, dopaminergic neuron apoptosis, and neuroinflammation in PD [107].